BC is very heterogenic and classified into distinct molecular subtypes based on hormone receptors, namely, estrogen receptor (ER)/progesterone receptor (PR), and growth factors, including human epidermal growth factor receptor 2 (HER2) and Ki-67 as a proliferation marker (2). This evidence concerns the gene ESR1 and breast cancer.